PMGC HOLDINGS INC. Income Taxes Receivable
PMGC HOLDINGS INC. (ELAB) had Income Taxes Receivable of $5.28 thousand as of 2024-12-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets
us-gaap:IncomeTaxReceivable · last filed 2025-05-14
- 2024-12-31: Income Taxes Receivable $5.28K.
| Period end | Income Taxes Receivable |
|---|---|
| 2024-12-31 | $5.28K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |